228 related articles for article (PubMed ID: 12076467)
1. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
2. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
[TBL] [Abstract][Full Text] [Related]
3. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
[TBL] [Abstract][Full Text] [Related]
4. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
5. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
Paul M; Soares-Weiser K; Leibovici L
BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
[TBL] [Abstract][Full Text] [Related]
6. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
[TBL] [Abstract][Full Text] [Related]
7. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials.
Paul M; Benuri-Silbiger I; Soares-Weiser K; Leibovici L
BMJ; 2004 Mar; 328(7441):668. PubMed ID: 14996699
[TBL] [Abstract][Full Text] [Related]
8. Anti-pseudomonal beta-lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta-lactams.
Paul M; Yahav D; Bivas A; Fraser A; Leibovici L
Cochrane Database Syst Rev; 2010 Nov; 2010(11):CD005197. PubMed ID: 21069685
[TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
Marcus R; Paul M; Elphick H; Leibovici L
Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
[TBL] [Abstract][Full Text] [Related]
11. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.
Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L
Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
[TBL] [Abstract][Full Text] [Related]
13. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
Falagas ME; Matthaiou DK; Bliziotis IA
J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
[TBL] [Abstract][Full Text] [Related]
14. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Yahav D; Fraser A; Leibovici L
J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
[TBL] [Abstract][Full Text] [Related]
15. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
[TBL] [Abstract][Full Text] [Related]
16. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
[TBL] [Abstract][Full Text] [Related]
17. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Paul M; Dickstein Y; Borok S; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; (1):CD003914. PubMed ID: 24425445
[TBL] [Abstract][Full Text] [Related]
18. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
[TBL] [Abstract][Full Text] [Related]
19. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Elphick HE; Tan A
Cochrane Database Syst Rev; 2001; (1):CD002007. PubMed ID: 11279745
[TBL] [Abstract][Full Text] [Related]
20. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
